Among patients with stage I lung cancer who underwent radical surgery, the five-year survival rate was significantly higher in COX-2-negative cases (88%) compared to cases with COX-2 overexpression (66%) [78]. The gene discussed is PTGS2; the disease is lung carcinoma.